Thursday, 06 October 2022

SRL Diagnostics & Roche Diagnostics India to unveil 'Laboratory of the Future'

16 March 2022 | News

The latest integrated system installation will optimize lab resources while providing high-quality results and valued clinical information to clinicians

image credit- shutterstock

image credit- shutterstock

SRL Diagnostics is all set to transform its lab at Fortis Memorial Research Institute with Roche Diagnostics’ integrated analyser series.  With this installation, SRL Diagnostics is well on the path to establishing an Integrated Core Lab. This integration will bring enormous benefits to SRL and its patients.

The inauguration of the new breakthrough platform was done by Anand K, CEO, SRL Diagnostics along with Dr Ritu Mittal Garg, Zonal Director Fortis Memorial Research Institute and Narendra Varde, Managing Director, Roche Diagnostics India and Neighboring markets. 

Laboratories of the future will encompass integrated systems where lab technicians will no longer need to work in different labs for different disciplines. Instead, their multidisciplinary connectivity will allow a single centralized, automation system to include a single user interface that can run the entire system. 

“Diagnostic tools are vital in improving patient care by enabling clinicians to make medical decisions accurately. Labs today want to offer the best but need integrated systems that can offer more. Therefore, demand for increased lab productivity and efficiency per invested space and budget continues to rise. High performing labs need an efficient mix of a broad test menu and fast result turnaround time. The cobas analyzer series consolidates 230+ tests including innovative tests on maternal screening, Alzheimer’s disease, cardiac risks etc. on one system, where most of these samples utilize just a single tube of blood sample. It can also achieve 99% per cent uptime, or 18 minutes or less TAT on 93 per cent of parameters ”, said Narendra Varde, Managing Director, Roche Diagnostics India & Neighboring Markets.''  

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account